Vyome Therapeutics, Inc.

Vyome Therapeutics, Inc. company information, Employees & Contact Information

Vyome Therapeutics Inc. is laser-focused on unmet medical needs and addressing them with novel therapeutic products that regulate the immuno-inflammation response. We rely on 3 principles to create impact and value: Focus on unmet medical need: We differentiate from the crowd by truly diving deep into our medical knowledge and expertise to identify significant unmet medical needs that currently have no approved products. We select only those unmet needs that can be clinically addressed and offer a clear regulatory path for development. Create strong mechanistic IP around treating the disease: We leverage a strong mechanistic understanding of the causes and drivers of the disease to identify the best target, the optimal product, and tractable clinical endpoints. A strong mechanistic basis also allows us to create new IP. Vyome has over 75 patents granted or pending. Laser focus on smart clinical trial design and execution: We bring a thoughtful and creative approach to clinical development. We are laser focused on (1) The right patient pool, (2) Identifying endpoints that are meaningful and achievable; and (3) Trial design that enable the generation of registrational data in a cost-effective manner. These 3 principles, interlinked, allow us to maximize impact and value while minimizing risks and costs.
Looking for a particular Vyome Therapeutics, Inc. employee's phone or email?

Vyome Therapeutics, Inc. Questions

News

Insights from Vyome on Building a Global Biotech Network - Pharmaceutical Executive

Insights from Vyome on Building a Global Biotech Network Pharmaceutical Executive

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell - Business Wire

Vyome To Mark First Day of Trading as HIND with Nasdaq Opening Bell Business Wire

Vyome to review strategic options for majority-owned Livechain - Investing.com

Vyome to review strategic options for majority-owned Livechain Investing.com

Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow - Nasdaq

Vyome To Begin Trading On Nasdaq Via Reverse Merger With ReShape Lifesciences Tomorrow Nasdaq

Vyome to replace ReShape leadership as it prepares for Nasdaq listing - Investing.com

Vyome to replace ReShape leadership as it prepares for Nasdaq listing Investing.com

Vyome Holdings Acquires MIT AI Spinout Oculo Health - Business Wire

Vyome Holdings Acquires MIT AI Spinout Oculo Health Business Wire

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” - Yahoo Finance

Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND” Yahoo Finance

Vyome to begin trading as Vyome Holdings under HIND symbol - Investing.com

Vyome to begin trading as Vyome Holdings under HIND symbol Investing.com

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity - Business Wire

Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity Business Wire

Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market - Investing.com

Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market Investing.com

ReShape And Vyome To Merge In All-stock Deal; ReShape To Substantially All Of Its Assets To Biorad - Nasdaq

ReShape And Vyome To Merge In All-stock Deal; ReShape To Substantially All Of Its Assets To Biorad Nasdaq

Reverse Merger Offers Vyome Cost Effective Route to Go Public - Pharmaceutical Executive

Reverse Merger Offers Vyome Cost Effective Route to Go Public Pharmaceutical Executive

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies - Yahoo Finance

Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies Yahoo Finance

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity - Business Wire

Vyome Holdings Announces Positive Interim Data from Phase 2 Study of VT-1953 in Malignant Fungating Wounds (MFW) and Provides Update on MFW market opportunity Business Wire

Vyome therapeutics to list on nasdaq as HIND after reshape merger - Investing.com Nigeria

Vyome therapeutics to list on nasdaq as HIND after reshape merger Investing.com Nigeria

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics - Business Wire

ReShape Lifesciences Announces Shareholder Approval of Merger with Vyome Therapeutics Business Wire

Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio - Business Wire

Vyome Signs MoU with Embryyo, India’s Leading Medical Device Innovation Studio Business Wire

ReShape and Vyome to merge in all-stock deal - Investing.com

ReShape and Vyome to merge in all-stock deal Investing.com

Vyome Announces Strategic Review of Livechain (OTCID: LICH) - Business Wire

Vyome Announces Strategic Review of Livechain (OTCID: LICH) Business Wire

Vyome Holdings Appoints Dr. Richard Fahrner as CTO and Dr. Tamara Agajanov, MD, as SVP – Clinical Development - citybiz

Vyome Holdings Appoints Dr. Richard Fahrner as CTO and Dr. Tamara Agajanov, MD, as SVP – Clinical Development citybiz

Vyome Holdings expands at-the-market offering and appoints new auditor - Investing.com

Vyome Holdings expands at-the-market offering and appoints new auditor Investing.com

Vyome lists on Nasdaq as HIND after ReShape merger - Times of India

Vyome lists on Nasdaq as HIND after ReShape merger Times of India

ReShape Lifesciences® Enters Into Merger Agreement With - GlobeNewswire

ReShape Lifesciences® Enters Into Merger Agreement With GlobeNewswire

ReShape Lifesciences Enters into a Merger Agreement with Vyome Therapeutics - Medical Product Outsourcing

ReShape Lifesciences Enters into a Merger Agreement with Vyome Therapeutics Medical Product Outsourcing

Vyome Biosciences Closes $14 Million Series C Financing - PR Newswire

Vyome Biosciences Closes $14 Million Series C Financing PR Newswire

Vyome lists on Nasdaq as HIND after ReShape merger - MSN

Vyome lists on Nasdaq as HIND after ReShape merger MSN

Watch: Two 8-month-old white tiger cubs, Avni and Vyom released in Delhi zoo for public viewing - Times of India

Watch: Two 8-month-old white tiger cubs, Avni and Vyom released in Delhi zoo for public viewing Times of India

Vyome Biosciences | Under the skin - Mint

Vyome Biosciences | Under the skin Mint

Milind Soman to return as Captain Vyom in reboot? Fans curious after announcement - India TV News

Milind Soman to return as Captain Vyom in reboot? Fans curious after announcement India TV News

Curing Common Skin Disorders - Forbes India

Curing Common Skin Disorders Forbes India

TV Star Gashmeer Mahajani Opens Up About His Adorable Son Vyom In A Heartfelt Interview - News18

TV Star Gashmeer Mahajani Opens Up About His Adorable Son Vyom In A Heartfelt Interview News18

Ranjan Pai joins Vyome board - The Economic Times

Ranjan Pai joins Vyome board The Economic Times

Ishq Mein Marjawan 2's Ankit Siwach says Vyom loves doing things that people don't like - India Today

Ishq Mein Marjawan 2's Ankit Siwach says Vyom loves doing things that people don't like India Today

TV’s 'Captain Vyom' Milind Soman turns Ironman - Times of India

TV’s 'Captain Vyom' Milind Soman turns Ironman Times of India

Indian Space Odyssey 2.0 - The Indian Express

Indian Space Odyssey 2.0 The Indian Express

Tom Alter Dies at 67: Shaktimaan’s Guru or Captain Vyom’s Boss, Roles Only '90s Kids Will Remember - India.Com

Tom Alter Dies at 67: Shaktimaan’s Guru or Captain Vyom’s Boss, Roles Only '90s Kids Will Remember India.Com

Vedaanta Senior Living Launches Vyom, In-House Tech Platform to Enhance Senior Care - The Realty Today

Vedaanta Senior Living Launches Vyom, In-House Tech Platform to Enhance Senior Care The Realty Today

Sharanya to recreate ‘Karz’ moment for Vyom in Sony TV’s Ek Deewaana Tha - IWMBuzz

Sharanya to recreate ‘Karz’ moment for Vyom in Sony TV’s Ek Deewaana Tha IWMBuzz

The challenge is to bring out the badness, as I am not like Vyom in real life: Vikram Singh Chauhan - IWMBuzz

The challenge is to bring out the badness, as I am not like Vyom in real life: Vikram Singh Chauhan IWMBuzz

#HappyFathersDay: My best moment as father was when I held my son in my arms for the first time: Gashmeer Mahajani of Imlie fame - IWMBuzz

#HappyFathersDay: My best moment as father was when I held my son in my arms for the first time: Gashmeer Mahajani of Imlie fame IWMBuzz

Vyom to be back in his old-age avatar in Sony TV’s Ek Deewaana Tha - IWMBuzz

Vyom to be back in his old-age avatar in Sony TV’s Ek Deewaana Tha IWMBuzz

Sharanya on a ‘mission’ to save Vyom’s life in Sony TV’s Ek Deewana Tha - IWMBuzz

Sharanya on a ‘mission’ to save Vyom’s life in Sony TV’s Ek Deewana Tha IWMBuzz

Union Bank of India Launches Super App – Union Vyom App - News Experts

Union Bank of India Launches Super App – Union Vyom App News Experts

Vyom-Sharanya’s sizzling romance on the original track ‘Deewangi Teri’ - IWMBuzz

Vyom-Sharanya’s sizzling romance on the original track ‘Deewangi Teri’ IWMBuzz

Top Vyome Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant